Entries by Comunicaciones C4C

Cells for Cells US patent granted for bioinspired grafts. An accelerator for the transition from medical research to medical practice

Cells for Cells announces that the U.S. Patent and Trademark Office (USPTO) has granted the patent covering the AUTOMATED FABRICATION OF LAYER-BY-LAYER TISSUE ENGINEERED COMPLEX TUBES (US20180304502). The approval now legally protects this invention which details a new strategy to fabricate advanced tissue engineered conduits for diverse applications intended to treat major medical conditions that […]

Cells for Cells and Austrianova announce publication on novel method to produce stem cell exosomes

Austrianova and Cells for Cells have just jointly published a ground breaking, peer reviewed, scientific publication on a novel, cost and time-saving method to generate extra-cellular vesicles (EVs) from encapsulated Mesenchymal Stem Cells (MSCs). These EVs are known to mediate many of the therapeutic effects of stem cells. The authors show that Austrianova’s proprietary Cell-in-a-Box encapsulation technology can […]

New automated technology for small diameter vascular grafts fabrication developed by Cells for Cells

The study, conducted by the Chilean biotech company Cells for Cells was published in Nature Communications journal. The automated approach allows the assembly of bio-inspired structural configurations enabling the fabrication of small-bore grafts that exhibit mechanical response and compliance of human coronary arteries. Global deaths attributed to cardiovascular disease are expected to reach 22.2 million […]

A Chilean cell-based clinical trial in osteoarthritis reveals the superiority of repetitive MSC injections to Hyaluronic Acid treatment

The study, made by the Chilean biotech company Cells for Cells and Universidad de los Andes Clinical Center, was published in STEM CELLS Translational Medicine journal. The work shows that patients with knee osteoarthritis treated with the allogeneic umbilical cord MSC-based therapy branded as CELLISTEM® OA, experienced a significant improvement in pain reduction, increased mobility […]

Strong attendance, new regulation and growing regional interest mark the annual meeting of the Brazilian Association for Cell Therapy (ABTCEL)

A total of 277 attendees, a record number of 128 selected abstracts and 56 national and international speakers were the figures bolstering up the growing interest for cell therapy in the SCA region. ISCT participated in this successful event, in Sao Paulo, through a joint session focusing on clinical applications. The ISCT awards for best […]

Cardiac risk in Chileans How do we help to face this challenge?

At the end of January, the Ministry of Health announced the second delivery of the results of the National Health Survey (ENS). Among other indicators, it reveals that 25.5 percent of the Chilean population is in the category of high cardiovascular risk. The are many factors and, without a doubt, it is an important challenge […]

Mega showed the history of the Chilean fencer Rubén Silva

Rubén Silva opted by cell therapy. Four years ago, he began to suffer sporadic pains in his wrist that were presented in certain activities that required effort, something unexpected and decisive to practice the sport that he is passionate about and which he is one of the best exponents in Latin America, fencing. When the […]

Nueva Mujer magazine highlighted Miacell therapy

The therapy, developed by Cells for Cells, is highlighted as part of a story informing about new facial rejuvenation treatments with high technology. The story, says that the facial treatments destined to rejuvenate the skin are increasingly advanced and painless. Miacells stands out as a non-invasive procedure, which leaves no visible traces and allows the […]

Primera patente otorgada a C4C: construcción de la protección de nuestra propiedad intelectual

Cumpliendo un primer ciclo que comenzó el año 2013 con las primeras solicitudes internacionales de patentes, el 1° de noviembre de 2017, Cells for Cells recibió la concesión de su primera patente. Otorgada por la European Patent Office, la invención “Menstrual Stem Cells for the efficient support and expansion of CD34 + CD133 + hematopoietic […]